Ryan Specialty (RYAN) Competitors

Ryan Specialty (NYSE:RYAN) and Manulife Financial (NYSE:MFC) are both large-cap finance companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, institutional ownership, risk, profitability, analyst recommendations and dividends.

Which has higher valuation & earnings, RYAN or MFC?

Manulife Financial has higher revenue and earnings than Ryan Specialty. Manulife Financial is trading at a lower price-to-earnings ratio than Ryan Specialty, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ryan Specialty	$2.65B	6.57	$94.67M	$0.34	195.56
Manulife Financial	$38.90B	1.35	$4.11B	$1.91	16.07

Does the media favor RYAN or MFC?

In the previous week, Manulife Financial had 2 more articles in the media than Ryan Specialty. MarketBeat recorded 14 mentions for Manulife Financial and 12 mentions for Ryan Specialty. Manulife Financial's average media sentiment score of 1.22 beat Ryan Specialty's score of 0.62 indicating that Manulife Financial is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ryan Specialty	6 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive
Manulife Financial	9 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Do analysts prefer RYAN or MFC?

Ryan Specialty presently has a consensus target price of $74.83, indicating a potential upside of 12.55%. Manulife Financial has a consensus target price of $48.50, indicating a potential upside of 58.06%. Given Manulife Financial's stronger consensus rating and higher possible upside, analysts plainly believe Manulife Financial is more favorable than Ryan Specialty.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ryan Specialty	1 Sell rating(s)	3 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.58
Manulife Financial	0 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	3.00

Is RYAN or MFC more profitable?

Manulife Financial has a net margin of 9.58% compared to Ryan Specialty's net margin of 6.97%. Ryan Specialty's return on equity of 47.70% beat Manulife Financial's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ryan Specialty	6.97%	47.70%	5.69%
Manulife Financial	9.58%	15.84%	0.75%

Is RYAN or MFC a better dividend stock?

Ryan Specialty pays an annual dividend of $0.48 per share and has a dividend yield of 0.7%. Manulife Financial pays an annual dividend of $1.28 per share and has a dividend yield of 4.2%. Ryan Specialty pays out 141.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Manulife Financial pays out 67.0% of its earnings in the form of a dividend. Ryan Specialty has raised its dividend for 1 consecutive years and Manulife Financial has raised its dividend for 12 consecutive years. Manulife Financial is clearly the better dividend stock, given its higher yield and longer track record of dividend growth.

Which has more volatility and risk, RYAN or MFC?

Ryan Specialty has a beta of 0.66, suggesting that its share price is 34% less volatile than the S&P 500. Comparatively, Manulife Financial has a beta of 0.99, suggesting that its share price is 1% less volatile than the S&P 500.

Do institutionals & insiders hold more shares of RYAN or MFC?

84.8% of Ryan Specialty shares are held by institutional investors. Comparatively, 52.6% of Manulife Financial shares are held by institutional investors. 52.2% of Ryan Specialty shares are held by company insiders. Comparatively, 0.0% of Manulife Financial shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

Summary

Manulife Financial beats Ryan Specialty on 13 of the 20 factors compared between the two stocks.